These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 23111138)

  • 1. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
    Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
    Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
    Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
    Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation.
    Sandberg F; Corino VD; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Platonov PG; Sörnmo L
    J Electrocardiol; 2015; 48(5):861-6. PubMed ID: 26275982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
    Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
    BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.
    Botto GL; Bonini W; Broffoni T
    Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
    Koh KK; Song JH; Kwon KS; Park HB; Baik SH; Park YS; In HH; Moon TH; Park GS; Cho SK
    Int J Cardiol; 1995 Nov; 52(2):167-74. PubMed ID: 8749878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study.
    Inoue H; Atarashi H; Okumura K; Yamashita T; Fukuzawa M; Shiosakai K; Kimura T
    J Cardiol; 2017 Jan; 69(1):293-301. PubMed ID: 27364549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of variability and irregularity of heart rate in patients with permanent atrial fibrillation: relation to symptoms and rate control drugs.
    Corino VD; Platonov PG; Enger S; Tveit A; Ulimoen SR
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2152-7. PubMed ID: 26497961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
    Allen LaPointe NM; Governale L; Watkins J; Mulgund J; Anstrom KJ
    Am Heart J; 2007 Nov; 154(5):893-8. PubMed ID: 17967595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
    Groenveld HF; Crijns HJ; Van den Berg MP; Van Sonderen E; Alings AM; Tijssen JG; Hillege HL; Tuininga YS; Van Veldhuisen DJ; Ranchor AV; Van Gelder IC;
    J Am Coll Cardiol; 2011 Oct; 58(17):1795-803. PubMed ID: 21996393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation.
    Enge K; Tveit A; Enger S; Onarheim S; Pripp AH; Rønningen PS; Solberg MG; Byrkjeland R; Andresen K; Halsen A; Aulie HA; Steinsvik T; Hall C; Ulimoen SR
    Eur Heart J Cardiovasc Pharmacother; 2024 Oct; 10(6):515-525. PubMed ID: 38702844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation.
    Demircan C; Cikriklar HI; Engindeniz Z; Cebicci H; Atar N; Guler V; Unlu EO; Ozdemir B
    Emerg Med J; 2005 Jun; 22(6):411-4. PubMed ID: 15911947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.